Cargando…
Biomarkers for Malignant Pleural Mesothelioma—A Novel View on Inflammation
SIMPLE SUMMARY: In view of the recent advances in immunoncology, we want to reevaluate and summarize the role of the immune system in malignant pleural mesothelioma (MPM). MPM is an aggressive disease with limited treatment options and devastating prognosis. Exposure to asbestos and chronic inflamma...
Autores principales: | Vogl, Melanie, Rosenmayr, Anna, Bohanes, Tomas, Scheed, Axel, Brndiar, Milos, Stubenberger, Elisabeth, Ghanim, Bahil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916017/ https://www.ncbi.nlm.nih.gov/pubmed/33562138 http://dx.doi.org/10.3390/cancers13040658 |
Ejemplares similares
-
A novel mutation of the folliculin gene causing Birt–Hogg–Dubé syndrome as rare cause for secondary pneumothorax
por: Vogl, Melanie, et al.
Publicado: (2020) -
Tumour cell PD-L1 expression is prognostic in patients with malignant pleural effusion: the impact of C-reactive protein and immune-checkpoint inhibition
por: Ghanim, Bahil, et al.
Publicado: (2020) -
Lymph but Not Blood Vessel Invasion Is Independent Prognostic in Lung Cancer Patients Treated by VATS-Lobectomy and Might Represent a Future Upstaging Factor for Early Stages
por: Biesinger, Melanie, et al.
Publicado: (2022) -
Circulating biomarkers in malignant pleural mesothelioma
por: Viscardi, Giuseppe, et al.
Publicado: (2020) -
Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma
por: Ghanim, B, et al.
Publicado: (2014)